Approved for OTULFI (ustekinumab-aauz) is a human interleukin-12 and -23 antagonist indicated for: adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy; active psoriatic arthritis; moderately to severely active Crohn's disease; and moderately to severely active ulcerative colitis. Also indicated for pediatric patients 6 years and older with…
Loading full data from Know Your Drugs Institute…